Lv11
60 积分 2026-03-01 加入
Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD): Mechanisms, Clinical Implications and Therapeutic Advances
18分钟前
已关闭
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
39分钟前
已完结
Model-informed prediction of human pharmacokinetics and first-in-human dose selection of J2H-1702, a novel 11β-hydroxysteroid dehydrogenase type 1 inhibitor for metabolic-associated steatohepatitis
2个月前
已关闭
The enedioic acid analog 326E alleviates metabolic dysfunction-associated steatohepatitis via dual targeting at ACLY and PPARα
2个月前
已完结
皖公网安备34019202002308
